{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:03:38Z","timestamp":1783109018974,"version":"3.54.6"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"M\u00e9dopale"},{"name":"NorOx"},{"name":"Sant\u00e9lys"},{"name":"LVL"},{"name":"Adair"},{"name":"Aeris Sant\u00e9"},{"name":"France Oxyg\u00e8ne"},{"name":"VitalAire"},{"DOI":"10.13039\/501100014160","name":"Agence R\u00e9gionale de Sant\u00e9 Hauts-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014160","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Homeperf"},{"name":"Sant\u00e9o"},{"DOI":"10.13039\/100020270","name":"SOS Oxyg\u00e8ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020270","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elivie"},{"name":"Sysmed"},{"name":"VentilHome"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the short-term and long-term benefits of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation (PR) programme in people with chronic obstructive pulmonary disease (COPD). Primary hypothesis was that 8 home-based supervised sessions will be equivalent to 16 home-based supervised sessions at both short- and long-term after PR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study conducted on prospectively collected real-life data, from January 2010 to December 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>FormAction Sant\u00e9, P\u00e9renchies France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Eligible individuals were aged &gt;18 years with a diagnosis of COPD and referred to the home-based PR programme by their respiratory physician. Participants were retrospectively divided into two groups (Gr 1, 8 PR sessions, n=759,\u2009and Gr 2, 8 PR sessions+8 educational sessions, n=262).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>All participants received an 8-week personalised home PR programme. A subgroup of participants received one additional supervised home session per week, including education and motivational support for daily physical activities and walking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Health-related quality of life, dyspnoea, anxiety and depressive symptoms, fatigue and exercise tolerance were assessed at baseline (M0), at the end of PR (M2), and 14 months (M14) after M0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline characteristics and assessments were similar between groups with an exception for long-term oxygen therapy (Gr1: 69.8% vs Gr2 53.0%, p&lt;0.001) and noninvasive ventilation (Gr1: 38.6% vs Gr2: 29.8%, p=0.015). At M2 and M14, all the assessments were improved in both groups (p&lt;0.01). At M2, the improvement in health status and exercise tolerance was higher in Gr 2 compared with Gr 1 (p&lt;0.05). From M0 to M14, 90 (11.9%) participants and 29 (11.1%) participants died in Gr 1 and Gr 2, respectively (p=0.794).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>People with COPD benefited, at short and long terms, from both 8 or 16 supervised home-based PR sessions. Once-weekly home-based supervised sessions during 8 weeks, combined with unsupervised physical training sessions and self-management plan for the other health behaviours, might be the best compromise between patients, health professionals and policy makers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-092096","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:26:13Z","timestamp":1736267173000},"page":"e092096","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Is longer really better? Results of a retrospective real-life cohort study evaluating the benefit of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation programme in people with COPD"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0801-7416","authenticated-orcid":false,"given":"Sarah","family":"Gephine","sequence":"first","affiliation":[{"name":"FormAction Sant\u00e9, F-59840 P\u00e9renchies, France"},{"name":"Univ. Lille, Univ. Artois, Univ. Littoral C\u00f4te D\u2019opale, ULR 7369-URePSSS - Unit\u00e9 de Recherche Pluridisciplinaire Sport Sant\u00e9 Soci\u00e9t\u00e9, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Le Rouzic","sequence":"additional","affiliation":[{"name":"Univ. Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, U1019 - UMR 9017- CIIL - Center for Infection and Immunity of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Peres","sequence":"additional","affiliation":[{"name":"Sant\u00e9lys HAD, F-59120 Loos, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Chenivesse","sequence":"additional","affiliation":[{"name":"Univ. Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, U1019 - UMR 9017- CIIL - Center for Infection and Immunity of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Grosbois","sequence":"additional","affiliation":[{"name":"FormAction Sant\u00e9, F-59840 P\u00e9renchies, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2025121603094725000_15.1.e092096.1","article-title":"Pulmonary rehabilitation for chronic obstructive pulmonary disease","volume":"2015","author":"McCarthy","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121603094725000_15.1.e092096.2","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2012.758696"},{"key":"2025121603094725000_15.1.e092096.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00145613"},{"key":"2025121603094725000_15.1.e092096.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1066ST"},{"key":"2025121603094725000_15.1.e092096.5","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0761-8425(10)70005-X","article-title":"R\u00e9habilitation du patient atteint de BPCO","volume":"27","year":"2010","journal-title":"Rev Mal Respir"},{"key":"2025121603094725000_15.1.e092096.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.11.016"},{"key":"2025121603094725000_15.1.e092096.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-12-200812160-00006"},{"key":"2025121603094725000_15.1.e092096.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208514"},{"key":"2025121603094725000_15.1.e092096.9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/crj.13138","article-title":"The impact of home-based pulmonary rehabilitation on people with mild chronic obstructive pulmonary disease: A randomised controlled trial","volume":"14","author":"Lahham","year":"2020","journal-title":"Clin Respir J"},{"key":"2025121603094725000_15.1.e092096.10","doi-asserted-by":"publisher","DOI":"10.1177\/1479972311404256"},{"key":"2025121603094725000_15.1.e092096.11","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.048173"},{"key":"2025121603094725000_15.1.e092096.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2006.11.007"},{"key":"2025121603094725000_15.1.e092096.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.physio.2009.04.007"},{"key":"2025121603094725000_15.1.e092096.14","first-page":"2037","article-title":"Long-term evaluation of home-based pulmonary rehabilitation in patients with COPD","volume":"10","author":"Grosbois","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025121603094725000_15.1.e092096.15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MCP.0000000000000460","article-title":"Self-management strategies in chronic obstructive pulmonary disease: a first step toward personalized medicine","volume":"24","author":"Barrecheguren","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"2025121603094725000_15.1.e092096.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"2025121603094725000_15.1.e092096.17","doi-asserted-by":"publisher","DOI":"10.3917\/spub.064.0513"},{"key":"2025121603094725000_15.1.e092096.18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(85)92589-9","article-title":"Anxiety and depression in inpatients","volume":"2","author":"Lepine","year":"1985","journal-title":"Lancet"},{"key":"2025121603094725000_15.1.e092096.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00392-6"},{"key":"2025121603094725000_15.1.e092096.20","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-6-46","article-title":"The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease","volume":"6","author":"Puhan","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"2025121603094725000_15.1.e092096.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.05.004"},{"key":"2025121603094725000_15.1.e092096.22","first-page":"9","article-title":"Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease","volume":"4","author":"Perez","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025121603094725000_15.1.e092096.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00102509"},{"key":"2025121603094725000_15.1.e092096.24","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204119"},{"key":"2025121603094725000_15.1.e092096.25","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.7.581"},{"key":"2025121603094725000_15.1.e092096.26","first-page":"657","article-title":"Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients","volume":"11","author":"Grosbois","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025121603094725000_15.1.e092096.27","doi-asserted-by":"publisher","DOI":"10.1177\/1479972316647178"},{"key":"2025121603094725000_15.1.e092096.28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000446517","article-title":"Responsiveness and Minimally Important Difference of the 6-Minute Stepper Test in Patients with Chronic Obstructive Pulmonary Disease","volume":"91","author":"Pichon","year":"2016","journal-title":"Respiration"},{"key":"2025121603094725000_15.1.e092096.29","first-page":"1","article-title":"Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature","volume":"12","author":"Giacomini","year":"2012","journal-title":"Ont Health Technol Assess Ser"},{"key":"2025121603094725000_15.1.e092096.30","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208506"},{"key":"2025121603094725000_15.1.e092096.31","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212765"},{"key":"2025121603094725000_15.1.e092096.32","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1513\/AnnalsATS.202102-146ST","article-title":"Defining Modern Pulmonary Rehabilitation","volume":"18","author":"Holland","year":"2021","journal-title":"Off Am Thorac Soc Workshop Rep Ann Am Thorac Soc"},{"key":"2025121603094725000_15.1.e092096.33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00025-2016"},{"key":"2025121603094725000_15.1.e092096.34","doi-asserted-by":"crossref","unstructured":"Roche N , Anzueto A , Bosnic Anticevich S , et al . The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization. Eur Respir J 2019;54.","DOI":"10.1183\/13993003.01511-2019"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-092096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:09:57Z","timestamp":1765883397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-092096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-092096"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-092096","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}